Breaking News Instant updates and real-time market news.

TSLA

Tesla

$327.78

4.37 (1.35%)

15:17
07/17/17
07/17
15:17
07/17/17
15:17

Tesla stock low if you believe in company's future, Elon Musk says

Reference Link

  • 02

    Aug

  • 08

    Aug

  • 02

    Oct

TSLA Tesla
$327.78

4.37 (1.35%)

07/11/17
MSCO
07/11/17
NO CHANGE
Target $305
MSCO
Equal Weight
Morgan Stanley sees Tesla as 'expensive call option' on next-gen transportation
Following the recent pullback in Tesla (TSLA) shares, Morgan Stanley analyst Adam Jonas revisited his thoughts on the stock and concluded that, at current valuation, Tesla remains "a rather expensive call option" on the addressable markets of next-generation transportation and energy. With protectionism an increasing worry as Tesla threatens to "flood" international markets with its electric vehicles, Jonas sticks by his view that "very large and well capitalized" tech competitors, such as Apple (AAPL) and Alphabet (GOOGL) will be making "increasingly conspicuous" efforts to encroach on Tesla's territory. He maintains an Equal Weight rating and $305 price target on Tesla shares.
07/05/17
BARD
07/05/17
NO CHANGE
Target $368
BARD
Outperform
Tesla Q2 deliveries 'good enough,' says Baird
Baird analyst Ben Kallo says Tesla's s Q2 deliveries were "good enough" and in line with the lower end of the company's guidance. He believes investors will look forward to the Model 3 introduction on July 28. The analyst keeps an Outperform rating on the shares with a $368 price target.
07/05/17
COWN
07/05/17
NO CHANGE
Target $155
COWN
Underperform
Tesla shares remain overvalued, says Cowen
Cowen analyst Jeffrey Osborne notes that Tesla's Q2 deliveries came in 2,500 units below his expectations due to a production issue on 100 kWh batteries. Regarding Tesla CEO Elon Musk's tweets on Model 3 production, Osborne wrote, "While it is nice to see Tesla finally hit a stated target on time, we question whether 30 vehicle deliveries essentially built by hand count as 'mass production' and we also are surprised that this 'mass market' vehicle does not have official photos, options, pricing or really any details available (we expect this on Friday)." The analyst continues to view Model 3 ramp expectations as aggressive. He models for 4,500 Model 3 deliveries in 2017 and 62,500 in 2018. Osborne believes Tesla shares are overvalued and keeps an Underperform rating on the name with a $155 price target.
07/05/17
KEYB
07/05/17
NO CHANGE
KEYB
Tesla shares could still rise in near-term, says KeyBanc
KeyBanc analyst Brad Erickson says that Tesla's delivery report confirms his thesis that " demand run-rates for Tesla's high-end products is plateauing, if not peaking." However, the analyst believes that the stock could rise in the near-term because the Model 3 remains on schedule. But the analyst says that "as we get closer to 2018...the stock will reflect more rational investors views," based on his forecast that "half the profit pool is no longer growing and Model 3 profitability appears unlikely to meet expectations," Erickson keeps a Sector Weight rating on the stock.

TODAY'S FREE FLY STORIES

02:40
12/12/17
12/12
02:40
12/12/17
02:40
General news
FX Update: Narrow ranges have prevailed »

FX Update: Narrow ranges…

01:55
12/12/17
12/12
01:55
12/12/17
01:55
General news
FX Action: USD-JPY has plied a narrow 14 pip range »

FX Action: USD-JPY has…

NAV

Navistar

$40.07

0.17 (0.43%)

20:13
12/11/17
12/11
20:13
12/11/17
20:13
Upgrade
Navistar rating change at Stifel »

Navistar upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

GBT

Global Blood Therapeutics

$44.78

-0.925 (-2.02%)

20:10
12/11/17
12/11
20:10
12/11/17
20:10
Conference/Events
Global Blood Therapeutics to hold an investor webcast »

Management reviews the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

VMW

VMware

$121.09

1.52 (1.27%)

19:55
12/11/17
12/11
19:55
12/11/17
19:55
Conference/Events
VMware management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 17

    Jan

MMC

Marsh & McLennan

$83.93

-0.2 (-0.24%)

19:52
12/11/17
12/11
19:52
12/11/17
19:52
Conference/Events
Marsh & McLennan management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BG

Bunge

$69.67

-0.12 (-0.17%)

19:48
12/11/17
12/11
19:48
12/11/17
19:48
Conference/Events
Bunge management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

COP

ConocoPhillips

$51.69

0.12 (0.23%)

19:42
12/11/17
12/11
19:42
12/11/17
19:42
Conference/Events
ConocoPhillips management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

BL

BlackLine

$35.04

0.37 (1.07%)

19:36
12/11/17
12/11
19:36
12/11/17
19:36
Conference/Events
BlackLine management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 26

    Feb

AGIO

Agios Pharmaceuticals

$61.42

0.45 (0.74%)

19:25
12/11/17
12/11
19:25
12/11/17
19:25
Conference/Events
Agios Pharmaceuticals to hold an investor meeting »

Investor Meeting where…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SGEN

Seattle Genetics

$55.27

-3.995 (-6.74%)

19:25
12/11/17
12/11
19:25
12/11/17
19:25
Conference/Events
Seattle Genetics to hold an investor and analyst event »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 16

    Dec

TCBK

TriCo Bancshares

$41.34

-0.3 (-0.72%)

19:15
12/11/17
12/11
19:15
12/11/17
19:15
Hot Stocks
TriCo to acquire FNB in transaction valued at roughly $315.3M »

TriCo Bancshares and FNB…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLP

Archrock Partners LP

$11.41

0.19 (1.69%)

18:53
12/11/17
12/11
18:53
12/11/17
18:53
Hot Stocks
Archrock Partners LP names Raymond Guba interim CFO of general partner »

Archrock Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AROC

Archrock

$9.80

0.3 (3.16%)

, APLP

Archrock Partners LP

$11.41

0.19 (1.69%)

18:49
12/11/17
12/11
18:49
12/11/17
18:49
Hot Stocks
Archrock names Raymond Guba Interim CFO »

Archrock announced that…

AROC

Archrock

$9.80

0.3 (3.16%)

APLP

Archrock Partners LP

$11.41

0.19 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAV

Advantage Oil & Gas

$4.05

0.05 (1.25%)

18:33
12/11/17
12/11
18:33
12/11/17
18:33
Hot Stocks
Advantage Oil & Gas announces 2018 capital budget of $175M »

Advantage Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OJSCY

Rosneft

18:22
12/11/17
12/11
18:22
12/11/17
18:22
Upgrade
Rosneft rating change at Goldman Sachs »

Rosneft upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$24.85

-1.11 (-4.28%)

18:18
12/11/17
12/11
18:18
12/11/17
18:18
Recommendations
Glaukos analyst commentary at Piper Jaffray »

Piper sees 'another…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FATE

Fate Therapeutics

$4.14

-0.03 (-0.72%)

18:18
12/11/17
12/11
18:18
12/11/17
18:18
Hot Stocks
Fate Therapeutics reports Day 100 results from Phase 1 stage of PROTECT trial »

Fate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

GM

General Motors

$41.67

-0.35 (-0.83%)

18:14
12/11/17
12/11
18:14
12/11/17
18:14
Periodicals
GM CEO: Cutting EV tax credit 'will have an impact' on sales, Reuters says »

General Motors CEO Mary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 16

    Jan

EDIT

Editas Medicine

$23.60

-1.36 (-5.45%)

18:02
12/11/17
12/11
18:02
12/11/17
18:02
Hot Stocks
Editas Medicine reports results from expanded CRISPR genome editing strategies »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBH

First Mid-Illinois Bancshares

$39.09

0.42 (1.09%)

18:00
12/11/17
12/11
18:00
12/11/17
18:00
Hot Stocks
First Mid-Illinois Bancshares to acquire First BancTrust Corp for $73.8M »

First Mid-Illinois…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$120.42

0.5 (0.42%)

17:46
12/11/17
12/11
17:46
12/11/17
17:46
Initiation
Chevron initiated  »

Chevron initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPOR

Gulfport Energy

$13.13

0.67 (5.38%)

17:44
12/11/17
12/11
17:44
12/11/17
17:44
Initiation
Gulfport Energy initiated at Credit Suisse »

Gulfport Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$57.13

0.75 (1.33%)

17:43
12/11/17
12/11
17:43
12/11/17
17:43
Initiation
EQT Corporation initiated at Credit Suisse »

EQT Corporation initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTC

Bitcoin

, BITCOIN

Bitcoin

17:43
12/11/17
12/11
17:43
12/11/17
17:43
Hot Stocks
SEC Chairman says no initial coin offerings have been registered »

Securities and Exchange…

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.